In this paper Origins explore the concept of patient engagement in all stages of a product lifestyle, and why patient voices need to be loud, and heard, during all phases of drug development.
More “New White Paper”[20 January 2023]
In December 2022, Director of Origins, Su Smith was joined by Daniel de Schryver, Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa at Janssen and Emma Sutcliffe, Global Head of Patient Affairs at Ipsen to discuss and explore the integration of patient engagement in all stages of a product lifecycle.
The topics covered included; what does ‘end-to-end’ encompass, and what does this mean for drug development companies, regulators, healthcare professionals and, of course, patients themselves? Emma and Daniel brought their experience and expertise to the conversation, ensuring a lively and informative discussion.
You can find a recording of the Webinar in our ‘Knowledge Centre’. At 59 minutes long, it’s the perfect lunch break watch!
[30 November 2022]
Origins announces the first speaker on the panel of our upcoming webinar
Origins is hosting the next in its series of free webinars on Tuesday 13th December at 2pm UK time: “End-to-end patient strategy: making a treatment for patients, with patients”
Director of Origins, Su Smith will be joined by a panel of passionate industry experts to explore the integration of patient engagement in all stages of a product lifecycle. what does ‘end-to-end’ encompass, and what does this mean for drug development companies, regulators, healthcare professionals and, of course, patients themselves? The panel will discuss the past, present and future of patient engagement.
Our first confirmed speaker is Daniel de Schryver, Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa, Janssen…
More “FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients”[16 November 2022]
Origins is proud to sponsor this year’s PMEA award for Excellence in Patient Education and Support. This award highlights the importance of the patient within today’s healthcare environment…
More “Origins sponsors the PMEA award for Excellence in Patient Education and Support”[15 November 2022]
As active members of the BHBIA (British Healthcare Business Intelligence Association), Origins was honoured to host a recent educational webinar entitled “Improving health care by understanding patient sentiment & preference”.
It has long been known that if healthcare providers obtain an understanding of patients’ preferences relating to their care & treatment, then better decisions can be made. But how can pharma better understand patient sentiment and preferences, and why would they want to..?
More “Origins delivers ‘valuable’ and ‘insightful’ BHBIA webinar”[14 November 2022]
Resonant Group Chief Innovation Officer, Mark Corbett has released a video explain why Origins is evolving from a Patient Insights agency to a Patient Focused Specialist agency.
To watch the video please visit the Knowledge Centre section of this website and it can be found under ‘Our team talking about our work’. Whilst you are there, why not check out some of our other videos, articles and recording of our highly successful webinar series.
[1 November 2022] – Origins Insights, a Resonant Group company, today announced the evolution of its unique service offering to become an exclusively patient focused agency.
“Historically, the significant potential contribution of patients to the pre-clinical and clinical investigation of new therapies has been under-recognised,” said Mark Corbett, Chief Innovation Officer, Resonant Group, who will lead the new offering. “Our evolved suite of services builds on our ability to access deep patient insights at all stages of the drug lifecycle, from clinical development, through market access into commercialisation.”
More “Origins Insights Evolves Into Patient Specialist Agency”
©Copyright all rights reserved
